Paul A. Meyers
- Pulmonary and Respiratory Medicine top 0.05%
- Sarcoma Diagnosis and Treatment 152
- Rheumatology top 0.1%
- Bone Tumor Diagnosis and Treatments 36
- Oncology top 0.5%
- Vascular Tumors and Angiosarcomas 25
- Cancer Research top 0.5%
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 23
-
- Neuroblastoma Research and Treatments 35
-
- Cardiac tumors and thrombi 33
-
- Acute Lymphoblastic Leukemia research 17
-
- Testicular diseases and treatments 16
- Co-authors
- John H. HealeyRichard GörlickAndrew G. HuvosMichael P. LaQuagliaHeribert JuergensIan LewisGlenn HellerLeonard H. Wexler
- Journals
- New England Journal of Medicine (3 papers)The Lancet (1 paper)The Journal of Experimental Medicine (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Paul A. Meyers
258 papers receiving 15.3k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Pulmonary and Respiratory Medicine 9.0k
- Rheumatology 3.3k
- Oncology 4.2k
- Cancer Research 1.8k
- Pathology and Forensic Medicine 2.1k
Countries citing papers authored by Paul A. Meyers
This map shows the geographic impact of Paul A. Meyers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul A. Meyers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul A. Meyers more than expected).
Fields of papers citing papers by Paul A. Meyers
This network shows the impact of papers produced by Paul A. Meyers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul A. Meyers. The network helps show where Paul A. Meyers may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul A. Meyers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 13 | |
| 2 | 2024 | 2 | |
| 3 | 2022 | 6 | |
| 4 | 2022 | 15 | |
| 5 | 2019 | 98 | |
| 6 | 2016 | 2 | |
| 7 | 2012 | 184 | |
| 8 | 2012 | 53 | |
| 9 | 2011 | 252 | |
| 10 | 2011 | 23 | |
| 11 | 2010 | 166 | |
| 12 | Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Groupbreakdown → | 2008 | 520 |
| 13 | 2008 | 39 | |
| 14 | 2007 | 54 | |
| 15 | 2006 | 17 | |
| 16 | The MTOR inhibitor, rapamycin, inhibits growth of Ewing’s sarcoma in vitro and in vivo | 2005 | 1 |
| 17 | 1999 | 233 | |
| 18 | 1998 | 376 | |
| 19 | 1992 | 227 | |
| 20 | 1989 | 15 |
About Paul A. Meyers
Paul A. Meyers is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Oncology, having authored 262 papers that have together received 15.7k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (152 papers), Bone Tumor Diagnosis and Treatments (36 papers), Neuroblastoma Research and Treatments (35 papers), Cardiac tumors and thrombi (33 papers), Vascular Tumors and Angiosarcomas (25 papers), Lymphoma Diagnosis and Treatment (23 papers), Acute Lymphoblastic Leukemia research (17 papers) and Testicular diseases and treatments (16 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (9.0k citations), Rheumatology (3.3k citations) and Oncology (4.2k citations). Paul A. Meyers has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include John H. Healey, Richard Görlick, Andrew G. Huvos, Michael P. LaQuaglia, Heribert Juergens, Ian Lewis, Glenn Heller, Leonard H. Wexler, Mark Krailo and Holcombe E. Grier. Their work appears in journals such as New England Journal of Medicine, The Lancet and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.